Active Ingredient: ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
Proprietary Name: PLENVU
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: 7.54GM;140GM;2.2GM;48.11GM;5.2GM;9GM
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209381
Product Number: 001
Approval Date: May 4, 2018
Applicant Holder Full Name: SALIX PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
